Skip to main content
. 2020 Oct 9;12(10):950. doi: 10.3390/pharmaceutics12100950

Figure 5.

Figure 5

Preparation and characterization of biogenic HNPs. (A,B) Particle size and PDI, (C) surface charge, (D,E) TEM images.

HHS Vulnerability Disclosure